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Abstract
There is little understanding of the effect that reactive oxygen metabolites have on cellular behavior
during the processes of invasion and metastasis. These oxygen metabolites could interact with a
number of targets modulating their function such as enzymes involved in basement membrane
dissolution, adhesion molecules involved in motility or receptors involved in proliferation. We
investigated the effect of increased scavenging of superoxide anions on the expression of the
urokinase receptor (uPAR) in PC-3M human prostate cancer cells. Urokinase receptor is a GPI-
linked cell surface molecule which mediates multiple functions including adhesion, proliferation and
pericellular proteolysis. Addition of the superoxide scavenger 4-hydroxy-2,2,6,6-
tetramethylpiperidinyloxy (TEMPOL) to PC-3M cultures stimulated expression of uPAR protein
peaking between 48 and 72 hours. Cell surface expression of the uPAR was also increased.
Surprisingly, uPAR transcript levels increased only slightly and this mild increase did not coincide
with the striking degree of protein increase. This disparity indicates that the TEMPOL effect on
uPAR occurs through a post-transcriptional mechanism. TEMPOL presence in PC-3M cultures
reduced intracellular superoxide-type species by 75% as assayed by NBT dye conversion; however
this reduction significantly diminished within hours following TEMPOL removal. The time gap
between TEMPOL treatment and peak uPAR protein expression suggests that reduction of reactive
oxygen metabolites in prostate cancer cells initiates a multistep pathway which requires several
hours to culminate in uPAR induction. These findings reveal a novel pathway for uPAR regulation
involving reactive oxygens such as superoxide anion.
Findings
Reactive oxygen species (ROS) are becoming increasingly
associated with several aspects of cancer progression
including not only carcinogenesis but also tumor cell pro-
liferation and invasion [1]. In prostate cancer, oxygen rad-
icals are reported to arise from several sources within the
cells including the NADPH oxidase [1], mitochondrial
glycerophosphate-dependent ROS [2], xanthine oxidase
and nitric oxide synthases [3]. The cell's net redox state is
a balance between oxygen radical synthesis and break-
down, and net ROS metabolism in prostate cancer arises
via activities of the scavenger enzyme systems catalase,
superoxide dismutase I (Zn2+/Cu2+ SOD) and II (MN-
SOD), and glutathione peroxidase [3].
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It has previously been reported that increased ROS precip-
itates the increase of some matrix metalloproteinases [4].
In addition to the important role of these metalloprotein-
ases, prostate cancer invasion is also highly dependent
upon the activity of the urokinase proteinase system con-
sisting of the serine protease urokinase, its cell surface
receptor uPAR and inhibitors such as plasminogen activa-
tor inhibitors [5-8]. Despite the knowledge that both ROS
signaling and the urokinase receptor are key mediators of
prostate cancer progression, there are no reports to date
which have linked the two. We investigated the effect that
increased scavenging of superoxide could have on uPAR
expression. The superoxide scavenger used was TEMPOL,
a water soluble cell permeant piperidine nitroxide [9].
PC-3M cells were exposed to TEMPOL over a 24 hour
period, then the chemical was removed. This treatment
stimulated expression of uPAR protein first evident 48
hours after TEMPOL addition. This protein expression
peaked between 48 and 72 hours (Figure 1A). To correlate
protein levels with transcript expression, real-time PCR
was used to measure uPAR PCR product. Surprisingly,
only a small increase in RNA occurred and only at the 48
hour time period. The difference between the RNA levels
preceding and during the time points of striking protein
increase leads us to conclude that the effect of TEMPOL on
uPAR protein expression is mediated through largely post-
transcriptional mechanisms. To further determine if the
effect of TEMPOL on uPAR expression results directly
from TEMPOL exposure or rather through TEMPOL addi-
tion-then-withdrawal, we compared uPAR levels in cells
treated with TEMPOL for 24 hours followed by TEMPOL
removal with cells treated continuously with TEMPOL for
48 hours. These results demonstrate that continuous
TEMPOL treatment also results in increased uPAR protein,
although the level of uPAR increase is less than that seen
after the 24 hour-treat-then-withdrawal protocol. This
indicates that uPAR may be induced by the suppression of
superoxide which follows TEMPOL treatment (Figure 1B).
To determine the efficacy of TEMPOL treatment and the
length of the residual effect of TEMPOL following
removal, we quantitated the accumulation of superoxide-
type metabolites using NBT dye conversion in control and
TEMPOL-treated PC-3M cells. This assay revealed that
TEMPOL effectively reduced superoxide by approximately
75%; however, this effect lasted only while TEMPOL was
present in the culture (Figure 1C and 1D). The inhibitory
effect rapidly dissipated after TEMPOL removal. Immu-
nostaining demonstrates that the increased uPAR protein
induced by TEMPOL treatment leads to increased cell sur-
face expression (Figure 1E).
These data suggest a novel regulatory mechanism for
uPAR protein involving ROS such as superoxide anion
which is pharmacologically scavenged by TEMPOL. This
regulation appears to involve a significant degree of post-
transcriptional regulation and results in peak protein
expression after the TEMPOL effect on ROS dissipates. The
time gap between TEMPOL treatment and peak uPAR pro-
tein expression leads us to hypothesize that TEMPOL acts
through a multistep pathway which requires several hours
to produce increased uPAR. This pathway may either be
initiated during the period of TEMPOL treatment or initi-
ated by its withdrawal. Mechanistically, TEMPOL treat-
ment could alter the redox state of one or more target
proteins upstream of uPAR protein synthesis. Although
TEMPOL treatment reduces superoxide-type metabolites,
it is also possible that TEMPOL withdrawal creates a
rebound increase in oxygen radicals which promotes the
increased uPAR. To investigate this possible rebound phe-
nomenon, we treated PC-3M cells with TEMPOL for 48
hours and then extracted proteins. Immunoblot analysis
again showed an increase in uPAR expression suggesting
that the effects of TEMPOL treatment itself induces uPAR.
In addition to promoting cancer progression, uPAR main-
tains normal cellular attachment, proliferative signaling,
proteolysis and chemotaxis [10,11]; therefore our results
could indicate that modulation of uPAR expression by
oxygen metabolite levels is one of many regulatory checks
for maintenance of normal uPAR activity. However,
because both ROS and uPAR are associated with prostate
cancer progression it is tempting to speculate that regula-
tion of uPAR by oxygen metabolites could facilitate motil-
ity, proteolysis and invasion. Oxygen metabolites have
been shown to potentially regulate other proteins associ-
ated with invasion. For instance, Chiarugi et al [12] pro-
pose that ROS generated by integrin signaling inactivates
several protein tyrosine phosphatases. In NIH-3T3 fibrob-
lasts, inhibition of one of these phosphatases, low molec-
ular weight phosphatase, then facilitates the activation of
focal adhesion kinase [FAK, [12]].
FAK signaling is associated with prostate cancer metastasis
[] and therefore it is conceivable that ROS regulation of
FAK could facilitate invasion. ROS have also been shown
to induce uPAR in gastric cancer cells [14]; however in this
study uPAR was induced by generating a net increase in
oxygen radicals using H2O2 or a superoxide generator
(phenazine methosulfate). In addition, gastric cancer
uPAR induction by ROS was transcriptional and involved
AP-1 binding to the uPAR promoter region [14].
We have assumed that the TEMPOL effect we observed
occurs through its well known action as a scavenger of cer-
tain oxygen radicals particularly superoxide anion; how-
ever, we have not excluded the possibility that TEMPOL
induction of uPAR results from an alternative pharmaco-
logic reaction. Activity of enzymes such as superoxide dis-Molecular Cancer 2006, 5:21 http://www.molecular-cancer.com/content/5/1/21
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Transient TEMPOL treatment of PC-3M cells induces uPAR transcript and protein expression Figure 1
Transient TEMPOL treatment of PC-3M cells induces uPAR transcript and protein expression. (A). TEMPOL was added to 
cells (time 0) and then thoroughly washed away after 24 hours. Proteins were isolated at the time of TEMPOL removal (i.e. 24 
h) and at 48, 72 and 96 hours and these proteins were immunoblotted for uPAR expression (upper panel). β-actin loading is 
shown (lower panel). uPAR transcript expression relative to control (= to 1.0) measured using real-time PCR is shown beneath 
each band (mean transcript ± s. dev. (B). TEMPOL was added to cell cultures for either a 24 hour period followed by with-
drawal for another 24-hour period (labeled as "T × 24 h wd × 24 h"), or for a 48-hour continuous period (labeled as "T × 48 
h"). In both treatments, cells were lysed and proteins were extracted after 48 hours. Control cells were not treated. Upper 
panel shows uPAR protein expression; lower panel shows β-actin expression to verify equivalent loading. (C). NBT staining in 
untreated cells (left panel) and in cells treated with TEMPOL for 18 hours (right panel). Images photographed at 320× using 
varel contrast. (D). TEMPOL reduction of superoxide levels is reversed following its removal. Cells were stained using NBT 
beginning at the time points shown in order to detect intracellular superoxide levels. Bars reflect the degree of NBT staining as 
a percent of control (untreated) cells. During the 18 hour time point (cross-hatched bar), NBT was present in the cell culture. 
(E). uPAR cell surface staining (red) in control (left panel) vs. cells 48 hours after TEMPOL treatment (right panel) as above. 
Nuclei are shown following staining with DAPI (blue). Image taken at 630×.Molecular Cancer 2006, 5:21 http://www.molecular-cancer.com/content/5/1/21
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mutase will need to be altered in order to more
specifically identify the metabolic components that influ-
ence uPAR expression in prostate cancer. To further define
the pathway linking reactive oxygen metabolites and
uPAR, it will be necessary to identify redox-sensitive
molecular targets which can alter uPAR protein transla-
tion or half-live.
Materials and methods
Cell culture and treatments
PC3M cells were a gracious gift from Dr. Isiah Fidler (MD
Anderson Cancer Center, Houston TX). These cells were
maintained in Minimal Essential Medium with Earle's
salts (MEM), supplemented with 10% fetal bovine serum,
100 units/mL penicillin, 100 ug/ml streptomycin, and 2.0
mM L-glutamine.
To scavenge superoxide, cells were treated with 4 mM final
concentration of 4-hydroxy-2,2,6,6-tetramethylpiperidi-
nyloxy, free radical (TEMPOL, purchased from Sigma
Chemicals) diluted in HBSS-Ca, Mg. TEMPOL is a water
soluble analogue of the spin label TEMPO and is a stable
piperidine nitroxide which crosses the plasma membrane
and acts as either an SOD mimetic or as a scavenger of
superoxide anion [9].
Chromogenic detection of superoxide
Nitro blue tetrazolium salt (NBT) was solubilized in 70%
dimethyl formamide [15] then diluted in culture medium
to a final concentration of 250 uM and added to live PC-
3M cells for 6 hour periods. Cells were treated with TEM-
POL over a 24 hour period after which the scavenging
agent was removed. Conditions for this analysis were: 1)
NBT added during cell exposure to TEMPOL – 18 hours
after initial TEMPOL addition to culture media; 2). NBT
added immediately after removal of TEMPOL (24 hours
after TEMPOL addition); 3) NBT added 48 hours after ini-
tial TEMPOL addition; 4). NBT added 72 hours after TEM-
POL addition. NBT forms a water-insoluble blue
formazan when it reacts with intracellular superoxide
demonstrating the degree of superoxide formation within
the cell. To prepare for spectrophotometric analysis, cells
were incubated for 20 minutes in a solution of 20% SDS
and 50% dimethylformamide. The cells were detached
from 24-well plates using a standard pencil eraser head
and the cell solution was boiled for one minute to
enhance solubiliztion of the formazan crystals. Cellular
debris was removed by brief centrifugation and the super-
natant was then analyzed at 570 nm with a reference of
650 nm.
Immunofluorescence
Live cells were incubated overnight in growth medium
with 5.0 ug/mL primary antibody (anti uPAR mono-
clonal, R&D Systems) to label cell surface uPAR. The anti-
body and medium were washed away and cells were then
fixed in ice cold paraformaldehyde for 10 minutes. Para-
formaldehyde was removed and replaced with a solution
of phosphate-buffered saline (PBS) containing 2% goat
sera for 20 minutes to block non-specific binding sites.
Fluorescent-tagged secondary antibody (Alexa Fluor 594,
Molecular Probes Inc) was then added in the blocking
solution for one hour. Fluorescence was imaged through
a Zeiss Axiovert 200 fluorescent microscope and recorded
through an Olympus Q-Capture 5.1 mega pixel color dig-
ital camera.
Gene expression analyses
To perform reverse-transcriptase PCR, total RNA was
extracted from PC-3M cells using RNA Bee reagent (Tel
Test, Friendswood, TX). After denaturation at 65°C for 5
min, RNA (2 μg) was added to 20 μl of RT mixture (10 μg/
ml oligo(dT), 1× RT buffer, 0.5 mM each of four deoxynu-
cleosides, 1 unit/μl RNase out, and 10 units of avian mye-
loblastosis virus reverse transcriptase (Invitrogen
Corporation, Carlsbad, California). An RT minus control
showed no visible bands. The RNA was reverse transcribed
at 37°C for 60 min and 2 μl of the products were used as
the template for PCR. Real-time PCR was carried out in a
Real-time PCR System 7300 (Applied Biosystems) with
standard temperature protocol and iTaq SYBR green
supermix (Bio-Rad Corp.) in a 25 uL reaction volume. The
default thermocycler program for all genes was: 3 minutes
pre-incubation (95°C) followed by 40 cycles for 15 sec-
onds at 95°C and one minute at 60°C. The last cycle was
followed by melting curve analysis between 60 and 95°C.
The individual primer concentrations in all PCR reactions
were 200 nM. All amplifications were carried out in opti-
cally clear 96-well Gold PCR plate, Corning Inc.) with
optical adhesive cover films. Accumulation of PCR prod-
uct was detected by monitoring the increase in fluores-
cence of the reporter dye. Relative expression values were
obtained by normalizing Ct values of the tested genes
with Ct values of GAPDH using the 2-ΔΔCt method. The
primers used for uPAR were 5'-ATCAGACATGAGCTGT-
GAGAGG-3' and 5'-ACTACGGCTCTGAAGTCACCAC-3';
these primers generated a 194 bp. PCR product.
Western Blot analysis for uPAR has been previously
described [16].
Abbreviations




ROS reactive oxygen speciesPublish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Molecular Cancer 2006, 5:21 http://www.molecular-cancer.com/content/5/1/21
Page 5 of 5
(page number not for citation purposes)
Competing interests
The author(s) declare that they have no competing inter-
ests.
Authors' contributions
D.L. optimized and performed immunoblotting and PCR,
M.H. developed and performed PCR, A.P. developed the
NBT staining procedure and photographed fluorescent
and Varel images, J.F. and I.S. formulated experimental
design and methodologies, I.S. performed cell culture,
immunoblotting and wrote the manuscript.
Acknowledgements
This work was supported by funding through the LSU SVM CORP 61-0102 
and the Louisiana Board of Regents LEQSF-RD-A-10 grants to IS and by 
LEQSF-RD-A-06 to J.F.
References
1. Lim SD, Sun C, Lambeth JD, Marshall F, Amin M, Chung L, Petros JA,
Arnold RS: Increased Nox1 and hydrogen peroxide in prostate
cancer.  Prostate 2005, 62:200-207.
2. Chowdhury SK, Gemin A, Singh G: High activity of mitochondrial
glycerophosphate dehydrogenase and glycerophosphate-
dependent ROS production in prostate cancer cell lines.  Bio-
chem Biophys Res Commun 2005, 333:1139-1145.
3. Chiarugi P: Reactive oxygen species as mediators of cell adhe-
sion.  Ital J Biochem 2003, 52:28-32.
4. Shariftabrizi A, Khorramizadeh MR, Saadat F, Alimoghadam K, Safavi-
far F, Ebrahimkhani MR: Concomitant reduction of matrix met-
alloproteinase-2 secretion and intracellular reactive oxygen
species following anti-sense inhibition of telomerase activity
in PC-3 prostate carcinoma cells.  Mol Cell Biochem 2005,
273:109-116.
5. Festuccia C, Dolo V, Guerra F, Violini S, Muzi P, Pavan A, Bologna M:
Plasminogen activator system modulates invasive capacity
and proliferation in prostatic tumor cells.  Clin Exp Metastasis
1998, 16:513-528.
6. Rabbani SA, Xing RH: Role of urokinase (uPA) and its receptor
(uPAR) in invasion and metastasis of hormone-dependent
malignancies.  Int J Oncol 1998, 12:911-20.
7. Gavrilov D, Kenzior O, Evans M, Calaluce R, Folk WR: Expression
of urokinase plasminogen activator and receptor in conjunc-
tion with the ets family and AP-1 complex transcription fac-
tors in high grade prostate cancers.  Eur J Cancer 2001,
37:1033-1040.
8. Pulukuri SM, Gondi CS, Lakka SS, Jutla A, Estes N, Gujrati M, Rao JS:
RNA interference-directed knockdown of urokinase plas-
minogen activator and urokinase plasminogen activator
receptor inhibits prostate cancer cell invasion, survival, and
tumorigenicity in vivo.  J Biol Chem 2005, 280:36529-40.
9. Muscoli C, Cuzzocrea S, Riley DP, Zweier JL, Thiemermann C, Wnag
Z-Q, Salvemini D: On the selectivity of superoxide dismutase
mimetics and its importance in pharmacologic studies.  Brit J
Pharmacology 2003, 140:445-460.
10. Sturge J, Wienke D, East L, Jones GE, Isacke CM: GPI-anchored
uPAR requires Endo180 for rapid directional sensing during
chemotaxis.  J Cell Biol 2003, 162:789-794.
11. Alfano D, Franco P, Vocca I, Gambi N, Pisa V, Mancini A, Caputi M,
Carriero MV, Iaccarino I, Stoppelli MP: The urokinase plasmino-
gen activator and its receptor: role in cell growth and apop-
tosis.  Thromb Haemost 2005, 93:205-211.
12. Chiarugi P, Pani G, Giannoni E, Taddei L, Colavitti R, Raugei G,
Symons M, Borrello S, Galeotti T, Ramponi G: Reactive oxygen
species as essential mediators of cell adhesion: the oxidative
inhibition of a FAK tyrosine phosphatase is required for cell
adhesion.  J Cell Biol 2003, 161:933-944.
13. Cooper CR, Chay CH, Pienta KJ: The role of alpha(v)beta(3) in
prostate cancer progression.  Neoplasia 2002, 4:191-194.
14. Kim MH, Cho HS, Jung M, Hong MH, Lee SK, Shin BA, Ahn BW, Jung
YD: Extracellular signal-regulated kinase and AP-1 pathways
are involved in reactive oxygen species-induced urokinase
plasminogen activator receptor expression in human gastric
cancer cells.  Int J Oncol 2005, 26:1669-74.
15. Aitken RJ, Buckingham D, Harkiss D: Use of a xanthine oxidase
free radical generating system to investigate the cytotoxic
effects of reactive oxygen species on human spermatozoa.
Reprod Fertil 1993, 97:441-450.
16. Forbes K, Gillette KM, Kelly L, Sehgal I: Urokinase Plasminogen
Activator Receptor (uPAR) is increased in re-metastasized
prostate cancer cells.  W Journal Urol 2004, 22:67-71.